What are the common recommended doses of filgotinib?

Filgotinib(Filgotinib), as a selective JAK1 inhibitor, is mainly used to treatrheumatoid arthritisand other immune-mediated diseases. It reduces the excessive response of the immune system by inhibiting the JAK1 signaling pathway, thereby reducing inflammation and tissue damage. The recommended dosage of filgotinib may vary for different diseases, but common dosage regimens are adjusted based on the patient's specific situation.

The standard recommended dose of filgotinib in the treatment of rheumatoid arthritis is usually 200 mg once daily. Patients can take it before or after meals, and they should pay attention to maintaining regularity and continuity when taking the medication. If the patient tolerates the drug poorly, the doctor may adjust the dose based on the patient's specific condition. For example, for some patients with abnormal liver function or other diseases, doctors may consider adjusting the dose, or decide whether to maintain the original dose or adjust to a lower dose based on the patient's clinical response.

It is important to emphasize that the dose of filgotinib may also be affected by the patient's other treatment options. For example, when filgotinib is used in combination with other immunosuppressants or antirheumatic drugs, dose adjustments should be carefully tailored based on the patient's treatment response and side effects. When using filgotinib, patients must regularly monitor blood indicators, such as white blood cell count, liver function, and kidney function, to ensure the safety and efficacy of the drug.

In certain circumstances, the dose of filgotinib may be individualized. For example, if a patient experiences serious side effects, or the drug is not working as well as expected, the doctor may recommend suspending the medication or adjusting the dose. In addition, factors such as the patient's age, weight, and severity of the condition may also affect dosage selection.

Reference materials:https://go.drugbank.com/drugs/DB14845